Apogee Therapeutics raises $169M to tackle immunological and inflammatory disorders
Apogee Therapeutics, LLC, a biotech company advancing novel, potentially best-in-class therapies to address immunological and…
December 7, 2022 - 2 minutes
Apogee Therapeutics, LLC, a biotech company advancing novel, potentially best-in-class therapies to address immunological and…